Safety and cost benefit of an accelerated infliximab infusion protocol in the treatment of ambulatory patients with inflammatory bowel diseases.

Abstract

BACKGROUND Infliximab is recommended to be infused over 2 h, but accelerated infusion rates of 30 min may improve efficiency, patient satisfaction and reduce nursing time and cost. The safety of this approach is not established. This study aims to assess the safety of accelerated infliximab infusion and determine the direct cost savings. METHODS The… (More)
DOI: 10.1517/14712598.2014.866649

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.